Summary
Updated Aug 31, 2026
Megan Smeykal is Chief Accounting Officer of TELA Bio, Inc. (TELA). 1 SEC Form 4 filing on record, dated 25 February 2026.
Recent Transactions
4Every recent SEC Form 4 transaction Megan Smeykal has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Megan Smeykal go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Megan Smeykal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EW HEALTHCARE PARTNERS FUND 2, L.P. - $4.00M of TELA open-market activity in the last 12 months
- Heather C. Getz - $19K of TELA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Megan Smeykal?
Megan Smeykal is a corporate insider, tracked as Chief Accounting Officer of TELA Bio, Inc. (TELA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Megan Smeykal last file a Form 4?
The only primary Form 4 on record is dated 25 February 2026.
Where can I see all of Megan Smeykal's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Megan Smeykal and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial